Neko Health is a Swedish health-tech company founded in 2018, focused on preventive healthcare and early disease detection through full-body scanning technology. The company's core product, the Neko Body Scan, maps millions of data points across skin, heart, circulation, tissue, and blood in minutes, generating insights on cardiovascular health, metabolic indicators, skin mapping, inflammation levels, and eye health. To date, the company has completed over 10,000 scans, with approximately 1% of patients identified as having serious, potentially life-threatening conditions, and 7% discovering significant health issues requiring attention.
The company has grown to over 500 employees and operates clinics in Stockholm, London, Manchester, and Birmingham, with plans to expand to New York City in 2026. Demand is substantial: over 300,000 people are on a global waitlist, and 80% of members rebook. Neko Health raised €260 million at a $1.8 billion valuation. Its technical work spans full-body scanning, data mapping, and preventive healthcare systems.
Neko Health's stated vision is to shift healthcare from reactive treatment to proactive prevention. The company reports operating with zero paid marketing, and many members pay a year in advance. Each scan includes an unrushed consultation with a doctor.
